GLP-1 drugs like Wegovy and Zepbound have been racking up sales and new indications, as researchers learn more about how the drugs affect the body beyond just weight loss. But one of the more anticipated studies exploring how they impact Alzheimer’s disease has found no meaningful effect, Novo Nordisk said in a press release on Nov. 24

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

What is reminiscence therapy? It's the approach Chris Hemsworth is using to fight his father's Alzheimer's disease in his new documentary.

A Harvard neurologist shares how many steps you should aim for each day for a healthy brain to prevent memory loss and cognitive decline.